Centenaire Biosciences
Seongnam
About Centenaire Biosciences
Centenaire Biosciences is a biopharmaceutical company that develops new drugs for cancer, immune diseases, and brain nerve diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $33.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2023)
- Website: ctnbio.com
- Phone: +82 31-703-6586
Industries & Categories
Biopharma, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/centenaire-biosciences-131021 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.